Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,462 total articles
Blue Owl (OWL) has been smashed by redemption headlines and forced liquidations, but the firm's underlying cash generation and a recent CEO commitment to return capital create a clear, actionable trade. Entry $10.90, stop $9.80, target $15.00 over a mid-term (45 trading days) horizon.
FormFactor looks poised for an earnings inflection driven by HBM4 design wins and a stronger ASP mix in probe cards and test sockets. This trade idea lays out an actionable long with entry at $38.00, a stop at $30.00 and staged targets at $55.00 and $72.00 across a 180-trading-day horizon.
Trinity Capital (TRIN) offers a 13%+ headline yield, a switch to monthly payouts, and valuation metrics (P/B ~1.13, P/E ~7.8) that look attractive versus the risk. This trade idea targets a mid-term rebound into the $17 area with a strict stop below $13.50 — a plan that balances income capture and capital preservation while acknowledging credit and…
Super Micro (SMCI) has ridden AI infrastructure demand to eye-popping revenue growth, yet investors are fretting margin erosion. With a market cap near $19.1B and a P/E in the low-20s, the stock looks priced for growth but not perfection. This trade targets a position-sized rebound over the next 46-180 trading days while protecting capital if margi…
Alphabet is down from its February highs after a market-wide tech pullback. The pullback has pushed the stock toward key short-term support, with fundamentals — $73.3B free cash flow, $3.7T market cap, and a 31.8% ROE — arguing this is a lower-risk re-entry for a mid-term swing. We lay out an actionable trade with precise entry, stop and target and…
Nvidia's fundamentals remain exceptional - 65% revenue growth and dominant margins - but the stock is under pressure because shareholders aren't getting meaningful direct rewards (dividends or buybacks). That combination increases sensitivity to sentiment and makes NVDA a candidate for a tactical short into key support. Trade plan included for a mi…
Dupixent's continued label expansion and durable demand combine with Regeneron's strong free cash flow and light leverage to make REGN an actionable long. The company trades at a reasonable P/E for a near-term growth story, and a targeted entry around $770 with a $720 stop and $840 target gives a constructive risk/reward over a 180 trading-day hori…
Rolls-Royce is a buy into a reopening of shareholder returns. Management has signaled a shift from restructuring to cash returns; with steady aftermarket service revenues, stronger defense demand and improving airline utilization, the stage is set for dividends and buybacks to lift investor sentiment. Trade plan provided with precise entry, stop an…
Gold.com, Inc. is a retail and wholesale precious-metals platform that benefits from rising bullion prices, retail flows into coins/collectibles, and a secured-lending business. At a market cap near $1.4–1.6B and free cash flow of ~$310M, GOLD trades cheaply versus cash-generation metrics despite a high PE. This trade idea lays out an actionable mi…
Five Point (FPH) trades at roughly 0.5x book with a market cap well below its free cash flow run-rate. We lay out an actionable long: entry $5.50, stop $4.50, target $11.25 over a long-term horizon (180 trading days). The setup is driven by outsized free cash flow, conservative leverage, and recoverable land-development optionality.
Liquidia (LQDA) enters 2026 as a small-cap commercial-stage biotech with an approved inhaled treprostinil (YUTREPIA) for PAH and PH-ILD, recent favorable litigation outcomes and early clinical readouts supporting adoption. The balance sheet and high valuation demand disciplined sizing, but the combination of label expansion, clinical data, and an a…
Trip.com (TCOM) looks attractive after a January regulatory scare that pushed shares sharply lower. Technicals show oversold conditions (RSI ~29.6) and a cheap valuation (PE ~8.4, PB ~1.53) against a $35.5B market cap. We outline a mid-term swing trade with clear entry, stop and target priced to the company’s recovery path as travel demand normaliz…
Pure Storage (PSTG) just dropped hard into the mid-$60s after a volatile session. Fundamentals and recent industry commentary point to durable demand from AI/hyperscaler customers plus successful price increases. The pullback compresses near-term technicals, presenting a defined-risk buying opportunity with a $66 entry, $60 stop and $95 target, hor…
Novo Nordisk has been sold off aggressively after a string of negative headlines: an underperforming CagriSema trial, a 50% list-price cut announcement and renewed competitive pressure from Eli Lilly. Those shocks are real, but the company’s market position in diabetes and obesity, a $165.8B market cap, a sub-11x P/E and a 3.27% dividend yield crea…
Joby sits at a make-or-break moment in 2026. With confirmed Uber-backed vertiports in Dubai, reported final FAA certification stages, and a new autonomy tie-up with Nvidia, upside is concentrated around successful certification and initial commercial flights. The trade below isolates a disciplined long exposure to capture that binary upside while a…
Hilton Grand Vacations (HGV) has the ingredients for a buyback-fueled rerating: a $4.0B market cap, improving technicals, modest free cash flow, and analyst upside to an average $62 target. With shares trading near $46.84 and a tight float, a disciplined repurchase program would likely boost EPS and ROE while compressing shares outstanding. This tr…
Ericsson American Depositary Shares ($11.47) looks like a pragmatic mid-term long: a $38B telecom-equipment franchise trading at a modest P/E with a healthy yield and improving technicals. Recent partnerships and 5G market tailwinds support upside, while elevated short interest and geopolitical risk argue for a disciplined entry and a conservative …
Micron has become the key memory supplier for the AI infrastructure buildout. Strong sales prints, expanding gross margins and sellouts of high-bandwidth memory position the company to extend its 2025-2026 rally. This trade idea outlines a precise entry at $416, stop at $360 and a $520 target across a structured time horizon.
Lockheed Martin offers predictable revenue, strong free-cash-flow generation, and direct exposure to accelerating missile defense and sustainment dollars. Valuation is not cheap but reasonable for a high-quality defense prime; this trade targets upside from program awards and continued FCF while protecting downside with a defined stop.
Shake Shack printed a strong Q4 with $400.5M in revenue (up 22% y/y), accelerated openings and guidance that points to mid‑teens growth in revenue for 2026. Valuation is rich on P/E but reasonable on EV/sales and growth-backed FCF potential. We recommend a mid-term long trade with a $98.65 entry, $86 stop and $130 target on expectations of sustaine…
ExlService (EXLS) is down from its 52-week high, but with durable cash flow, strong ROE, and an expanding AI product stack (Databricks partnership + Life Digital Suite recognition), the risk/reward looks attractive. Trade plan: enter $30.00, stop $27.50, target $38.00 over a long-term (180 trading days) horizon.
The RealReal's marketplace expansion and retail reopening are translating into higher take-rates and operating leverage. Recent top-line beats and improving margin commentary, combined with a reasonable $1.45B market cap and falling short interest, create a mid-term long trade that targets the 52-week high as EBITDA gains materialize.
AMD pulled back into the low $200s after a volatile session, but the company's AI GPU and EPYC CPU ramps, plus new hyperscaler wins, make a long trade with defined risk attractive. Entry $203.70, stop $182.00, target $275.00 over a 180-trading-day horizon.
The Honest Company (HNST) is trading up after heavy volume and recent product and distribution catalysts. With a net-cash style balance sheet (cash $1.59 per share, debt-to-equity 0), a $313.6M market cap and improving technical momentum, we view the current setup as a tactical long for traders willing to ride an operational turnaround into higher …
Insulet’s Omnipod adoption and international expansion keep revenue growth visible, free cash flow is healthy, and recent guidance raises show the company is executing. The stock trades below its 52-week high but still at a premium multiple; this trade idea lays out a long entry at $252 with a $310 target and $235 stop, sized for a long-term horizo…
